Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_provenance.
- NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_assertion description "[The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_provenance.
- NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_assertion evidence source_evidence_literature NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_provenance.
- NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_assertion SIO_000772 18556336 NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_provenance.
- NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_assertion wasDerivedFrom gad-20130706 NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_provenance.
- NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_assertion wasGeneratedBy ECO_0000203 NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_provenance.
- gad-20130706 importedOn "2013-07-06" NP74542.RAkZHq2GqEgt8D6jhxR-Zln1hwxi_Sv3f_lfe5hfoL0nM130_provenance.